“Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway” (2019) Biomolecules and Biomedicine, 19(1), pp. 52–59. doi:10.17305/bjbms.2018.3399.